PTC Therapeutics | PTCT - Trade Debtors


PTC Therapeutics reported $181.62M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.38M 153K Mar/2026
Alnylam Pharmaceuticals USD 883.96M 106.39M Mar/2026
Amgen USD 9.14B 432M Mar/2026
BioCryst Pharmaceuticals USD 106.82M 15.49M Dec/2025
Biogen USD 1.79B 76.6M Mar/2026
BioMarin Pharmaceutical USD 903.91M 4.3M Mar/2026
Cytokinetics USD 6.83M 10.94M Mar/2026
Daiichi Sankyo JPY 695.95B 79.1B Dec/2025
Enanta Pharmaceuticals USD 40.16M 1.52M Dec/2024
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
Gilead Sciences USD 4.74B 172M Mar/2026
Incyte USD 1.05B 27.09M Mar/2026
Ionis Pharmaceuticals USD 74M 8M Mar/2026
Ironwood Pharmaceuticals USD 81.89M 5.68M Dec/2024
Karyopharm Therapeutics USD 26.18M 5.6M Dec/2025
Novartis USD 9.6B 2.69B Mar/2026
Pfizer USD 16.17B 332M Mar/2026
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Roche Holding CHF 11.9B 460M Dec/2025
Sangamo BioSciences USD 581K 110K Jun/2024
Sarepta Therapeutics USD 547.91M 149.68M Mar/2026
TG Therapeutics USD 392.05M 86.42M Mar/2026
Ultragenyx Pharmaceutical USD 60M 98M Mar/2026
Vertex Pharmaceuticals USD 2B 56.7M Mar/2026
Xencor USD 12M 17.3M Mar/2026